Console Herbal Formulations (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.73 M
as on 20-12-2024
- Revenue 47.63%
(FY 2020)
- Profit -1209.91%
(FY 2020)
- Ebitda -31.92%
(FY 2020)
- Net Worth -0.07%
(FY 2020)
- Total Assets 12.73%
(FY 2020)
About Console Herbal Formulations (India)
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.73 M.
Mercy Joseph and Austin Figurado serve as directors at the Company.
- CIN/LLPIN
U01403KL2008PTC023414
- Company No.
023414
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2008
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Console Herbal Formulations (India) Private Limited offer?
Console Herbal Formulations (India) Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Toner.
Who are the key members and board of directors at Console Herbal Formulations (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mercy Joseph  | Director | 17-Nov-2008 | Current |
| Austin Figurado | Director | 12-Mar-2021 | Current |
Financial Performance of Console Herbal Formulations (India).
Console Herbal Formulations (India) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 47.63% increase. The company also saw a substantial fall in profitability, with a 1209.91% decrease in profit. The company's net worth dipped by a decrease of 0.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Console Herbal Formulations (India)?
In 2020, Console Herbal Formulations (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 09 Mar 2015 | ₹2.91 M | Open |
The Indian Overseas Bank Creation Date: 26 Mar 2009 | ₹1.20 M | Open |
The Indian Overseas Bank Creation Date: 26 Mar 2009 | ₹0.62 M | Open |
How Many Employees Work at Console Herbal Formulations (India)?
Unlock and access historical data on people associated with Console Herbal Formulations (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Console Herbal Formulations (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Console Herbal Formulations (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
